Satsuma Pharmaceuticals, Inc. Patent Applications Rejected
2 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2020-02-14: Application 16791431; Invention INTRANASAL DHE FOR THE TREATMENT OF HEADACHE; Applicant Satsuma Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2019-05-16: Application 16414350; Invention Intranasal DHE for the Treatment of Headache; Applicant Satsuma Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2020-02-14 | 16791431 | INTRANASAL DHE FOR THE TREATMENT OF HEADACHE | Satsuma Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200179379A1 | Shunji HARUTA Nikhilesh N. SINGH John KOLLINS Salvador RICO | Japan United States United States United States | HAGHIGHATIAN, MINA |
| 2019-05-16 | 16414350 | Intranasal DHE for the Treatment of Headache | Satsuma Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190275036A1 | Shunji Haruta Nikhilesh N. Singh John Kollins Salvador Rico | Japan United States United States United States | HAGHIGHATIAN, MINA |